Your browser doesn't support javascript.
loading
Reversible skin and hair depigmentation during chemotherapy with dasatinib for chronic myeloid leukemia.
Fujimi, Akihito; Ibata, Soushi; Kanisawa, Yuji; Shibata, Takanori; Sakamoto, Hiroki; Yamada, Shota; Okuda, Toshinori; Takahashi, Sho; Minami, Shinya; Hashimoto, Akari.
Affiliation
  • Fujimi A; Department of Hematology and Oncology, Oji General Hospital, Tomakomai, Japan.
  • Ibata S; Department of Hematology and Oncology, Oji General Hospital, Tomakomai, Japan.
  • Kanisawa Y; Department of Hematology and Oncology, Oji General Hospital, Tomakomai, Japan.
  • Shibata T; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Sakamoto H; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Yamada S; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Okuda T; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Takahashi S; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Minami S; Department of Gastroenterology, Oji General Hospital, Tomakomai, Japan.
  • Hashimoto A; Department of Medical Oncology and Hematology, Sapporo Medical University, Sapporo, Japan.
J Dermatol ; 43(1): 106-7, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26434556

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pigmentation / Leukemia, Myeloid, Accelerated Phase / Dasatinib Limits: Female / Humans / Middle aged Language: En Journal: J Dermatol Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pigmentation / Leukemia, Myeloid, Accelerated Phase / Dasatinib Limits: Female / Humans / Middle aged Language: En Journal: J Dermatol Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom